- Q3 net income $1.34B vs $1.19B YoY
- Adjusted EPS $6.99 vs $4.71 consensus
Elevance Health lifted its 2026 EPS guidance to at least $22 ($29 adjusted) after a strong third quarter. Adjusted EPS of $6.99 beat the $4.71 consensus. Revenue rose to $51.43 billion, topping forecasts. Membership fell by 487,000.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.